The Procter & Gamble Company (NYSE:PG) Shares Acquired by GW Henssler & Associates Ltd.

GW Henssler & Associates Ltd. grew its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 2.1% in the 3rd quarter, Holdings Channel.com reports. The fund owned 4,088 shares of the company’s stock after buying an additional 85 shares during the period. GW Henssler & Associates Ltd.’s holdings in Procter & Gamble were worth $708,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in PG. Steele Capital Management Inc. acquired a new stake in shares of Procter & Gamble during the first quarter worth about $204,000. GAMMA Investing LLC lifted its holdings in Procter & Gamble by 67.2% in the second quarter. GAMMA Investing LLC now owns 26,803 shares of the company’s stock valued at $4,420,000 after acquiring an additional 10,777 shares during the period. Consilio Wealth Advisors LLC lifted its holdings in Procter & Gamble by 27.7% in the first quarter. Consilio Wealth Advisors LLC now owns 1,746 shares of the company’s stock valued at $283,000 after acquiring an additional 379 shares during the period. Welch Group LLC lifted its holdings in Procter & Gamble by 0.9% in the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares during the period. Finally, AMF Tjanstepension AB lifted its holdings in Procter & Gamble by 416.1% in the third quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after acquiring an additional 1,466,115 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG traded down $1.63 during trading hours on Tuesday, hitting $167.67. 1,675,400 shares of the stock were exchanged, compared to its average volume of 6,641,123. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock’s 50-day moving average price is $171.94 and its two-hundred day moving average price is $167.79. The company has a market cap of $394.87 billion, a price-to-earnings ratio of 29.03, a price-to-earnings-growth ratio of 3.64 and a beta of 0.41. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same period in the prior year, the business earned $1.83 EPS. Research analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.40%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $170.00, for a total transaction of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares of the company’s stock, valued at approximately $3,657,210. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 397,986 shares of company stock worth $67,642,430 in the last three months. 0.18% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on PG. Wolfe Research raised Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Stifel Nicolaus boosted their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a report on Monday, July 22nd. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $177.00.

Read Our Latest Analysis on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.